NCT04509726 2026-01-20
EBV Specific Cytokine Secreting TCR-T Cells in the Treatment of EBV-Positive Metastatic/Refractory Nasopharyngeal Carcinoma
Xinqiao Hospital of Chongqing
Phase 1/2 Completed
Clinical Trials
10 trialsNCT02795195 2025-08-07
Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma
Shanghai Proton and Heavy Ion Center
Phase 1/2 Completed
NCT06251050 2025-05-30
A Lithium-containing Mouthwash Prevention and Treatment of Oral Mucositis and Dysgeusia in Patients Undergoing Radiotherapy
West China Hospital
Phase 1/2 Completed
NCT03674567 2025-01-24
Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab
RAPT Therapeutics, Inc.
Phase 1/2 Completed
NCT02538510 2024-11-26
Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery
University of Washington
Phase 1/2 Completed
NCT01534585 2018-04-17
Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma
Taizhou Hospital
Phase 1/2 Completed
NCT02523430 2016-07-19
HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT01712919 2014-03-24
Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)
Jiangsu Cancer Institute & Hospital
Phase 1/2 Completed
NCT00212108 2012-04-02
A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839
National University Hospital, Singapore
Phase 1/2 Completed
NCT01449942 2011-10-10
NPC-DZ
Xiangya Hospital of Central South University
Phase 1/2 Completed